Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents (Q38920104)

7 September 2017

Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents (English)

1 reference

7 September 2017

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587994%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

5

Véronique Dartois

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587994%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Suresh B Lakshminarayana

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587994%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Tan Bee Huat

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587994%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Paul C Ho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587994%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Ujjini H Manjunatha

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587994%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Srinivasa P S Rao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587994%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

English

0 references

publication date

11 November 2014

1 reference

7 September 2017

11

1 reference

Journal of Antimicrobial Chemotherapy

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587994%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587994%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587994%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

857-867

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25587994%20AND%20SRC:MED&resulttype=core&format=json

The population dynamics and control of tuberculosis

31 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Totally drug-resistant tuberculosis in India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Can the pharmaceutical industry reduce attrition rates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Molecular properties that influence the oral bioavailability of drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

The challenge of new drug discovery for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Development of Mycobacterium tuberculosis whole cell screening hits as potential antituberculosis agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Biopharmaceutics, pharmacokinetics and pharmacodynamics of antituberculosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Clinical pharmacology and lesion penetrating properties of second- and third-line antituberculous agents used in the management of multidrug-resistant (MDR) and extensively-drug resistant (XDR) tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Pharmacokinetics and pharmacodynamics in the development of anti-tuberculosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Clinical pharmacokinetics of the antituberculosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

A good practice guide to the administration of substances and removal of blood, including routes and volumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Discovery of tetrahydropyrazolopyrimidine carboxamide derivatives as potent and orally active antitubercular agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

PA-824 exhibits time-dependent activity in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Pharmacokinetics and pharmacodynamics of TMC207 and its N-desmethyl metabolite in a murine model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU457

An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence

21 January 2018

1 reference

12 December 2020

Physicochemical properties of antibacterial compounds: implications for drug discovery

1 reference

12 December 2020

Direct determination of unbound intrinsic drug clearance in the microsomal stability assay

1 reference

12 December 2020

Beta-lactam antibiotics and transport via the dipeptide carrier system across the intestinal brush-border membrane

1 reference

12 December 2020

Generation of a set of simple, interpretable ADMET rules of thumb

1 reference

12 December 2020

Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.

1 reference

12 December 2020

Prediction of drug absorption using multivariate statistics

1 reference

12 December 2020